The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Abdominal MR Diffusion-Weighted Imaging in Oncology

DWI-MRI in liver, pancreas, kidney, and bowel cancer: detection and treatment response

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Radyoloji department. Book Appointment →

What is Abdominal MR Diffusion-Weighted Imaging in Oncology?

DWI-MRI uses paired motion-sensitizing gradients (Stejskal-Tanner sequence) to generate signal contrast based on water molecule mobility. Tumors with high cellularity and small extracellular space restrict diffusion, appearing bright on high b-value images and dark on ADC maps (low ADC = restricted diffusion = malignancy).

B-values: low (b=0-50, anatomical reference), intermediate (b=400-600, tumor detection), high (b=800-1500, lesion characterization). Whole-body DWI (WB-DWI/DWIBS) used for staging metastatic disease without ionizing radiation. ADC quantification: liver tumors typically <1.2 × 10⁻³ mm²/s suggest malignancy; benign cysts >2.5.

Clinical applications: hepatocellular carcinoma (HCC) detection in cirrhotic liver, liver metastases (especially with hepatobiliary contrast), pancreatic adenocarcinoma vs chronic pancreatitis, renal cell carcinoma characterization, prostate cancer (mp-MRI), peritoneal carcinomatosis, lymphoma, gynecologic cancers (cervical, endometrial), treatment response assessment (early ADC change predicts response in chemo/radiation), GIST follow-up after imatinib.

Symptoms

(DWI-MRI is an imaging technique, not a disease)
Performed for evaluation of:
Suspected liver tumors (HCC, metastases)
Pancreatic mass characterization (adenocarcinoma vs benign)
Renal mass evaluation (RCC vs benign)
Peritoneal disease/carcinomatosis
Whole-body cancer staging (lymphoma, multiple myeloma)
Treatment response assessment (early prediction)
Gynecologic cancer staging

Risk Factors

Indications for DWI-MRI in oncology:
Equivocal CT/US findings of liver lesion
Cirrhosis with surveillance for HCC
Pancreatic mass requiring tissue characterization
Renal lesion (cyst vs RCC)
Suspected peritoneal carcinomatosis
Whole-body staging when ionizing radiation contraindicated (pregnancy, pediatric)
Treatment response assessment (chemo/radiation)
Renal failure (alternative to gadolinium)
Gadolinium allergy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When physician requests abdominal MRI with DWI
  • Liver lesion requiring further characterization after CT/US
  • Cirrhotic patient with rising AFP or new liver mass
  • Pancreatic mass on imaging needing characterization
  • Suspected metastatic disease without extensive radiation exposure
  • Renal mass requiring evaluation
  • Treatment response assessment for known malignancy
  • Gynecologic cancer staging and follow-up

Treatment Methods

01
(DWI-MRI is diagnostic — not therapeutic)
02
MRI protocol: 1.5T or 3T scanner, abdominal coil
03
Sequences: T2 HASTE/SSFSE, in-phase/out-of-phase, T1 pre/post-contrast (Gd-EOB-DTPA for liver), DWI with multiple b-values
04
DWI acquisition: respiratory-triggered or breath-hold, multiple b-values (0, 50, 400, 800, sometimes 1000-1500)
05
ADC map calculation from b-value images
06
Patient preparation: 4-6 hours fasting (luminal distention), spasmolytic if needed
07
Image interpretation: high b-value (lesion bright), ADC map (lesion dark = restricted)
08
Quantitative ADC measurement (ROI-based)
09
Hepatobiliary contrast (Gd-EOB-DTPA) increases liver lesion detection
10
Whole-body DWI for systemic staging
11
Radiation-free, no IV contrast required for basic DWI
12
Reporting: lesion size, ADC value, restriction pattern, comparison with prior
13
Follow-up imaging based on findings

Which Department to Visit?

You can visit our Radyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Radyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

What Is MRI (Magnetic Resonance Imaging)?

Radyoloji

MRI uses a magnetic field and radio waves and is the gold standard for imaging the brain, spine, joints, and internal organs.

What Is CT (Computed Tomography)?

Radyoloji

Computed tomography provides rapid, detailed cross-sectional images in emergency, trauma, and oncology cases.

What Is Ultrasound (Ultrasonography)?

Radyoloji

Ultrasonography is radiation-free and is widely used in pregnancy follow-up and the evaluation of abdominal organs and superficial tissues.

What Is an X-ray (Plain Radiograph)?

Radyoloji

X-ray is the oldest and most widely used radiologic test, providing rapid diagnosis in bone and lung pathologies.

Mammography

Radyoloji

Mammography is specialized low-dose X-ray imaging of breast tissue that detects cancer, often before clinical palpation, and is the primary tool for breast cancer screening in women 40 and older per ACR/ESR guidelines.

Doppler Ultrasound

Radyoloji

Doppler USG is critical for evaluating deep vein thrombosis, carotid stenosis, and organ blood flow.

Angiography

Radyoloji

Angiography examines all vascular systems in the body in detail, especially the cardiac and cerebral vessels.

PET-CT (Positron Emission Tomography)

Radyoloji

PET-CT combines metabolic activity with anatomical imaging in cancer staging and treatment-response evaluation.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.